US: 800.298.5699
Int'l: +1.240.747.3093
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
|
Home > List All Publishers > PJB Publications USA Inc.
PJB Publications USA Inc.
Theta Reports has been providing high-quality comprehensive market research for business development, marketing and research and development professionals since 1970. Focusing on the medical device, diagnostic, biotech and pharmaceutical industries, Theta identifies market opportunities created by new and emerging technology. Our industry experts define market size, project future growth, analyze products and market forces and profile the key players to give you a competitive edge. The data is collected from a variety of sources, including first-hand interviews with well-placed individuals at major organizations, as well as painstaking research and other sources. When you use a Theta report, you get more...
|

|
|
|
|
< prev 1 2 3 next >
Use column headings to sort
|
Title
|
Published
|
Price
|
|
Advanced Wound Care Biologics: World Market Analysis
By: PJB Publications USA Inc.
The financial impact of chronic wound care is enormous. In the U.S. alone, $2.8 billion is spent annually to treat an estimated 3 to 5 million chronic wounds. According to U.S. healthcare statistics,
|
more...
Search inside this report
|
8/1/2002
|
$1,995.00
|
|
Anemia Management: World Drug Markets
By: PJB Publications USA Inc.
Anemia is an increasingly prevalent disorder and is becoming a major public health concern due to the silent nature of the condition.
This report is designed to present clinical and market positioning
|
more...
Search inside this report
|
7/1/2003
|
$2,195.00
|
|
Angiogenesis Stimulators & Inhibitors: The Emerging World Market
By: PJB Publications USA Inc.
Angiogenesis inhibitors burst on the public radar screen with the announcement that they had been shown to reduce malignant tumor size in mice. Although the excitement of the time has been tempered somewhat with additional
|
more...
Search inside this report
|
4/15/2002
|
$1,995.00
|
|
Antibiotics: Global Anti-Infectives Markets Vol. II
By: PJB Publications USA Inc.
Second volume in Theta’s three-part anti-infectives report series...
Theta’s in-depth analysis will provide you with:
Global market analysis of a dozen antibiotic drug classes
2008 market size and growth projections
Comprehensive
|
more...
Search inside this report
|
5/1/2004
|
$2,495.00
|
|
Antidepressants: World Prescription Drug Markets
By: PJB Publications USA Inc.
Antidepressants are currently the third-leading drug class by prescription revenues, generating estimated global sales of $17 billion in 2002. However, recent year-on-year growth levels slowed from 18% to just 5% following generic fluoxetine (Prozac) competitors
|
more...
Search inside this report
|
12/1/2003
|
$2,395.00
|
|
Antisense Therapeutics: The Emerging World Market
By: PJB Publications USA Inc.
Antisense therapeutics are the buzz of the biotech sector, promising to effectively treat many intractable diseases, including cancer, viral infections, and autoimmune diseases. Antisense works by blocking the mRNA transcripts used to produce disease-causing proteins.
|
more...
|
4/1/2002
|
$2,899.00
|
|
Antivirals: Global Anti-Infectives Markets Vol I
By: PJB Publications USA Inc.
Antiviral drugs are the main, if only, method of treatment of major viral disease conditions. This Theta Report is the first in a three-volume series of market research reports on global anti-infective drug markets.
|
more...
Search inside this report
|
10/1/2003
|
$2,495.00
|
|
Apoptosis-Based Therapeutics: Cell Death to Market Birth
By: PJB Publications USA Inc.
The market for therapeutic apoptosis modulators is currently only emerging. However, over the five-year time course of this analysis, significant progress is anticipated with respect to the realization of the incredible potential offered by certain
|
more...
Search inside this report
|
5/1/2004
|
$2,395.00
|
|
Autoimmune Disease Therapeutics Worldwide: Markets & Developments
By: PJB Publications USA Inc.
In the next five years, new therapeutic approaches will drive the market for autoimmune disorder treatments to grow at a rate of over 15%, to a value of over $21 billion by 2006. The third
|
more...
Search inside this report
|
1/1/2002
|
$2,500.00
|
|
Benign Prostatic Hyperplasia: Global Market Analysis of Treatments & Disease Management Implications
By: PJB Publications USA Inc.
By 2006, approximately 115 million men in the 50+ age bracket will suffer from benign prostatic hyperplasia. Although not life-threatening, the growth in incidence will drive the value of this market to nearly $10 billion.
|
more...
Search inside this report
|
6/29/2002
|
$1,995.00
|
|
Biopharming: The Emerging World Market of Plant-based Therapeutics
By: PJB Publications USA Inc.
Concerns with biopharmaceutical production have arisen, especially in terms of maximum output and costs. This report focuses on the production of biopharmaceutical and biologic products for human medicine in transgenic plants, also known as
|
more...
Search inside this report
|
11/1/2002
|
$2,300.00
|
|
Biotech 2002 Worldwide: State of the Biotechnology Industry
By: PJB Publications USA Inc.
Genomics. Proteomics. Advanced gas and liquid phase analysis. These are just a few of the techniques pioneered by the biotechnology industry. But these are just techniques, not therapies. How will these advanced technologies be used
|
more...
Search inside this report
|
2/1/2002
|
$2,799.00
|
|
Biotechnology Laboratory Products Market
By: PJB Publications USA Inc.
This report takes a comprehensive look at the current and future status of the marketplace for manufacturers and suppliers of instrumentation, equipment, supplies and reagents to the biotechnology industry. Over the last ten years, biotechnology
|
more...
Search inside this report
|
10/1/1997
|
$497.00
|
|
Cancer Diagnostics and Cancer Therapeutics : Global Markets and Developments
By: PJB Publications USA Inc.
This is a bundle of Cancer Therapeutics and Cancer Diagnostics.
Abstract from Cancer Diagnostics: Cancer is the second largest cause of death in developed
countries, accounting for nearly 1 in 5 of all
|
more...
|
5/1/2003
|
$3,995.00
|
|
Cancer Diagnostics: Global Markets and Developments
By: PJB Publications USA Inc.
Cancer is the second largest cause of death in developed
countries, accounting for nearly 1 in 5 of all deaths. The financial
costs of cancer are staggering, affecting both the individual and
|
more...
|
2/1/2003
|
$2,999.00
|
|
Cancer Therapeutics: Global Markets and Developments
By: PJB Publications USA Inc.
Cancer accounts for approximately 22% of all deaths, which makes it the second leading cause of death in the U.S. after heart disease. The quest for effective cancer treatments continues to be one of the
|
more...
Search inside this report
|
9/1/2002
|
$2,400.00
|
|
Cardiovascular Biocompatible Devices: Markets for Stents, Catheters, & Beyond
By: PJB Publications USA Inc.
Cardiovascular devices are a $12.8 billion global industry that will grow on average of 12% per year through 2006, when it will be worth $22.6 billion...
This comprehensive title appraises existing and developing
|
more...
Search inside this report
|
10/1/2002
|
$2,600.00
|
|
Cardiovascular Diagnostics: World Market Trends and Analysis
By: PJB Publications USA Inc.
With cardiovascular disease still the leading cause of morbidity and mortality worldwide, the challenge now is to develop increasingly sensitive diagnostic modalities, especially in vitro diagnostic tests, that can solve the problem of early diagnosis
|
more...
|
3/1/2003
|
$2,999.00
|
|
Cardiovascular Drugs: Global Markets & Developments
By: PJB Publications USA Inc.
Cardiovascular Drugs: Global Markets & Developments
Due to the continuing strong demand for antihyperlipidemics, adrenergic blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, anticoagulants and antiplatelet agents, the total worldwide cardiovascular
|
more...
Search inside this report
|
4/7/2004
|
$2,495.00
|
|
Catheters: Global Markets & Technologies
By: PJB Publications USA Inc.
Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all medical catheters. Well over a hundred types of catheters are on the market today for
|
more...
Search inside this report
|
2/1/2004
|
$2,195.00
|
|
Computer Assisted Surgery
By: PJB Publications USA Inc.
Surgical automation systems-including surgical robots and virtual reality-are on the cusp of commercial viability, heralding a revolution in surgery in the 21st century. New systems promise to guarantee surgical accuracy, alleviate problems of operating room
|
more...
Search inside this report
|
12/1/2000
|
$2,295.00
|
|
Contact Lenses: Worldwide and U.S. Markets
By: PJB Publications USA Inc.
Driven by demographic pressures and new technologies, the contact lens market could reach $6.1 billion by 2006—a compound annual growth rate of almost 4%.
But: who will benefit from this growth? And how
|
more...
Search inside this report
|
5/1/2002
|
$2,394.00
|
|
Cosmeceuticals: Global Markets & Breakthrough Therapies
By: PJB Publications USA Inc.
Theta’s in-depth analysis will provide you with:
Overviews of currently available products in the major cosmeceutical market segments
Total world historic (1998-2003) and projected (2004-2008) market sizes, based on cosmeceutical product
|
more...
Search inside this report
|
6/1/2004
|
$2,395.00
|
|
Current and Future Generic Prescription Drugs: Global Market Analysis
By: PJB Publications USA Inc.
The global generic drug market is estimated to be between $19 and $22 billion, with compound growth of 11%-12% annually.
According to the U.S. Congressional Budget Office, generic drugs save consumers an estimated $8
|
more...
Search inside this report
|
9/1/2003
|
$2,395.00
|
|
Dermatologic & Skin Therapeutics: World Markets & Advances
By: PJB Publications USA Inc.
Dermatologic diseases affect an estimated 50 million Americans and result in over $2 billion in annual sales of prescription medications with an estimated yearly growth rate of 5% .
Theta’s report is designed to
|
more...
Buy by the section | Search inside this report
|
9/1/2003
|
$2,395.00
|
Title
|
Published
|
Price
|
|
|